Image

Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors

Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

Introduction :

The incidence of duodenal neuroendocrine tumors (DNETs) is increasing. Endoscopic resection is recommended for the management of small DNETs measuring ≤10 mm. Various endoscopic techniques have been utilized for the resection of DNETs including endoscopic mucosal resection (EMR), band ligation assisted EMR, endoscopic submucosal dissection (ESD). However, the published studies report a high rate of histologically incomplete resection even with ESD. More recently, device assisted endoscopic full thickness resection (EFTR) has emerged as a safe and effective resection modality in cases with upper and lower gastrointestinal (GI) mucosal as well as submucosal lesions. There is limited data on the outcomes of EFTR in cases with DNETs.

In this study, we aim to compare the rate of histologically complete resection (R0) with ESD and EFTR in cases with DNETs.

Description

Primary objective:

Rate of R0 resection in both the groups

Secondary outcomes:

  1. Technical success: defined as en-bloc resection of the lesion without any residual lesion endoscopically
  2. Procedure duration
  3. Adverse Events

Inclusion criteria:

  1. Adult patients (≥18 years) with biopsy proven duodenal neuroendocrine tumors (DNETs)
  2. Size of the lesion <15 mm
  3. Absence of local and distant metastases (EUS and DOTANOC scan)
  4. Willing to provide informed consent

Exclusion criteria:

  1. Large lesions >15 mm
  2. Invasion of muscularis layer and beyond on imaging (EUS)
  3. Scarring or deformity in duodenum
  4. Active duodenal ulcer
  5. History of prior resection
  6. Coagulopathy

Eligibility

Inclusion Criteria:

  1. Adult patients (≥18 years) with biopsy proven duodenal neuroendocrine tumors (DNETs)
  2. Size of the lesion <15 mm
  3. Absence of local and distant metastases (EUS and DOTANOC scan)
  4. Willing to provide informed consent

Exclusion Criteria:

  1. Large lesions >15 mm
  2. Invasion of muscularis layer and beyond on imaging (EUS)
  3. Scarring or deformity in duodenum
  4. Active duodenal ulcer
  5. History of prior resection
  6. Coagulopathy

Study details
    Neuroendocrine Tumors

NCT06121752

Asian Institute of Gastroenterology, India

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.